Daniel Bowers, M.D.
Associate Professor
Department: Pediatrics
Associate Professor
Department: Pediatrics
General Address
5323 Harry Hines Blvd.
Dallas, TX 75390-9063
| Medical School | UT Southwestern Medical Center (1993) |
| Internship | Children's Medical Center - GME (1994), Pediatrics |
| Residency | Children's Medical Center - GME (1996), Pediatrics |
| Fellowship | Johns Hopkins School of Medicine (1999), Pediatric Hematology/oncology |
Featured Publications
Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents
Bowers DC, Gargan L, Kapur P, Reisch JS, Mulne AF, Shapiro KN, Elterman RD, Winick NJ, Margraf LR Journal of Clinical Oncology 2006 21 2963 - 2973
Stroke as a late treatment effect of Hodgkin’s disease: a report from the Childhood Cancer Survivor Study
Bowers DC. McNeil DE. Liu Y. Yasui Y. Stovall M. Gurney JG. Hudson MM. Donaldson SS. Packer RJ. Mitby PA. Kasper CE. Robison LL. Oeffinger KC. Journal of Clinical Oncology 2005 23 6508-6515
Late-occurring stroke among long-term survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study.
Bowers DC, Liu Y, Leisenring W, McNeil E, Stovall M, Gurney JG, Robison LL, Packer RJ, Oeffinger KC. Journal of Clinical Oncology 2005 24 5277-5282
Phase I study of oral cyclophosphamides and oral topotecan for children with recurrent or refractory solid tumors
Bowers DC, Aquino VM, Leavey PJ, Bash RO, Journeycake JM, Tomlinson G, Mulne AF, Haynes HJ, Winick NJ Pediatric Blood and Cancer 2004 42 93-98
Hepatocyte growth factor activates the Akt pathway and inhibits chemotherapy and radiation induced cell death in human glioma cells
Bowers DC, Fan S, Willimas JA, Rosen EM, Laterra J Cancer Research 2000 60 (15) 4277-4283
Predictors of tumor progression among children with gangliogliomas
El-Khashab MA, Gargan L, Margraf L, Koral K, Nejat F, Weprin B, Swift D. Bowers, DC Journal of Neurosurgery - Pediatrics 2009 3 461-466
High-risk populations identified in Childhood Cancer Survivor Study investigations: implications for risk-based surveillance.
Hudson MM, Mulrooney DA, Bowers DC, Sklar CA, Green DM, Donaldson SS, Oeffinger KC, Neglia JP, Meadows AT, Robison LL Journal of Clinical Oncology 2009 27 2405-2414
Intermediate grade meningeal melanocytoma of cervical spine.
El-Khashab MA, Koral K, Bowers DC, Johnson-Welch S, Swift D, Nejat F Child’s Nervous System 2009 25 407-410
A single-arm, open label multi-institutional phase II study of multi-agent intrathecal and systemic chemotherapy with radiation therapy for children with newly-diagnosed central nervous system atypical teratoid/rhabdoid tumor
Chi SN, Zimmerman MA, Yao X, Fletcher W, Cohen K, Burger P, Biegel J, Rorke-Adams LF, Fisher M, Janss A, Mazewski C, Goldman S, Manley P, Bowers DC, Bendel A, Rubin J, Turner CD, Marcus K, Goumnerova L, Roberts C, Ullrich N, Chordas C, Kieran MW Journal of Clinical Oncology 2009 27 385-389
The impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma
Bowers DC, Gargan L, Weprin BE, Mulne AF, Elterman RD, Munoz L, Giller CA, Winick NJ Journal of Neurosurgery - Pediatrics 2007 107 5-10